Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea

Clinical trial NCT01137136 · SUSPENDED

Trial details

NCT number: NCT01137136
Sponsor: Samsung Medical Center
Status: SUSPENDED
Study type: OBSERVATIONAL

Polymorphism CYP19 Aromatase Inhibitor

Start date: 2010-06-01
Primary completion: 2014-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.